The Biomedical Research Response to COVID-19: A View from NIAID

NIH COVID-19 SIG Lecture Series NIAID has a long-standing dual mandate to maintain a robust portfolio of research in its key focus areas and to respond to emerging and re-emerging infectious diseases (EIDs). With this mandate, NIAID has also sought to improve EID-response preparedness, working in partnership with other U.S. government research entities, industry, academia, and international public-health organizations. This preparedness planning helped the institute respond rapidly to COVID-19. NIAID tapped existing coronavirus expertise and other assets to stand up research programs spanning basic virology and immunology through to countermeasure development (diagnostics, therapeutics, and vaccines). As the outbreak has expanded, so too has the NIAID research program and the scope of the problems it seeks to solve. As the COVID-19 pandemic has grown, it has become increasingly clear that the biomedical research response must draw upon the collective expertise of many NIH Institutes and Centers. Dr. Marston is a medical officer and Policy Advisor for Global Health at the National Institute of Allergy and Infectious Diseases (NIAID), focusing on emerging infectious disease preparedness and response. In this role, she coordinates the NIAID response to outbreaks including Zika, Ebola, and now COVID-19. Marston trained in internal medicine and global health equity at Brigham& Women's Hospital, during which time she worked with Partners in Health and the Clinton Health Access Init...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video